Cavicchio Charles M DPM is categorized under Podiatrists in Lincoln, RI and active since 2005.
Cavicchio Charles M DPM was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Podiatrists business, which does work in the B2C market, and is classified as a Podiatrists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Charles Cavicchio at the company’s single location by writing to 2 Wake Robin Road Unit 203, Lincoln, Rhode Island RI 02865 or by phoning (401) 312-9999. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cavicchio Charles M DPM |
| Contact Person: | Charles Cavicchio |
| Address: | 2 Wake Robin Road Unit 203, Lincoln, Rhode Island 02865 |
| Phone Number: | (401) 312-9999 |
| Website Address: | cavicchiopodiatry.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Podiatrists |
| SIC Code: | 8043 |
| NAICS Code: | 6211110 |
| Share This Business: |
Cavicchio Charles M DPM was started in 2005 to provide professional Podiatrists under the SIC code 8043 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Charles Cavicchio for inquiries that concern Cavicchio Charles M DPM by calling the company number (401) 312-9999, as your correspondence is most welcome. Additionally, the physical location of the single location of Cavicchio Charles M DPM can be found at the coordinates 41.93427,-71.47491 as well as the street address 2 Wake Robin Road Unit 203 in Lincoln, Rhode Island 02865.
For its online presence, you may visit Cavicchio Charles M DPM’s website at cavicchiopodiatry.com and engage with its social media outlets through on Twitter and on Facebook.